Publicaciones en colaboración con investigadores/as de Vrije Universiteit Brussel (38)

2016

  1. Synthesis and binding characteristics of [3H]neuromedin N, a NTS2 receptor ligand

    Neuropeptides, Vol. 57, pp. 15-20

2013

  1. [3H]IVDE77, a novel radioligand with high affinity and selectivity for the insulin-regulated aminopeptidase

    European Journal of Pharmacology, Vol. 702, Núm. 1-3, pp. 93-102

2012

  1. Angiotensin IV displays only low affinity for native insulin-regulated aminopeptidase (IRAP)

    Fundamental and Clinical Pharmacology, Vol. 26, Núm. 2, pp. 194-197

  2. Radiotracers, tritium labelling of neuropeptides

    Arkivoc, Vol. 2012, Núm. 5, pp. 163-174

2011

  1. Asymmetric synthesis and conformational analysis by NMR spectroscopy and MD of Aba- and α-MeAba-containing dermorphin analogues

    ChemMedChem, Vol. 6, Núm. 11, pp. 2035-2047

  2. Binding of " AT4 receptor" ligands to insulin regulated aminopeptidase (IRAP) in intact Chinese hamster ovary cells

    Molecular and Cellular Endocrinology, Vol. 339, Núm. 1-2, pp. 34-44

  3. Design, synthesis, pharmacological evaluation, and structure-activity study of novel endomorphin analogues with multiple structural modifications

    Journal of Medicinal Chemistry, Vol. 54, Núm. 5, pp. 1462-1472

  4. Synthesis, biological evaluation, and automated docking of constrained analogues of the opioid peptide H-Dmt-d-Ala-Phe-Gly-NH 2 using the 4- or 5-methyl substituted 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one scaffold

    Journal of Medicinal Chemistry, Vol. 54, Núm. 19, pp. 6538-6547

2009

  1. Influence of ring substitution on the conformation and β-turn mimicry of 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one peptide mimetics

    Tetrahedron, Vol. 65, Núm. 11, pp. 2266-2278

  2. Selective labeling of IRAP by the tritiated AT4 receptor ligand [3H]Angiotensin IV and its stable analog [3H]AL-11

    Molecular and Cellular Endocrinology, Vol. 311, Núm. 1-2, pp. 77-86

2008

  1. Endomorphin-2 with a β-turn backbone constraint retains the potent μ-opioid receptor agonist properties

    Journal of Medicinal Chemistry, Vol. 51, Núm. 1, pp. 173-177

  2. Translocation of the insulin-regulated aminopeptidase to the cell surface: Detection by radioligand binding

    British Journal of Pharmacology, Vol. 154, Núm. 4, pp. 872-881

  3. β-homo-amino acid scan of angiotensin IV

    Journal of Medicinal Chemistry, Vol. 51, Núm. 7, pp. 2291-2296

2007

  1. Bradykinin analogs containing the 4-amino-2-benzazepin-3-one scaffold at the C-terminus

    Journal of Peptide Science, Vol. 13, Núm. 3, pp. 164-170

  2. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles

    Brain Research Bulletin, Vol. 74, Núm. 1-3, pp. 119-129

  3. β-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent δ opioid antagonists

    Journal of Medicinal Chemistry, Vol. 50, Núm. 2, pp. 328-333

2004

  1. Structure-Activity Study on the Phe Side Chain Arrangement of Endomorphins Using Conformationally Constrained Analogues

    Journal of Medicinal Chemistry, Vol. 47, Núm. 3, pp. 735-743

2002

  1. Application of a new chiral derivatizing agent to the enantioseparation of secondary amino acids

    Journal of Chromatography A

2001

  1. Direct chiral separation of unnatural amino acids by high-performance liquid chromatography on a ristocetin A-bonded stationary phase

    Chirality

  2. Unprecedented sigmatropic rearrangements leading to 2,3-dihydro-1H-2-benzazepine-3-carboxylic acid

    Journal of Organic Chemistry, Vol. 66, Núm. 8, pp. 2884-2886